According to research by Future Market Insights, The Psychobiotic Supplements market is anticipated to expand at a CAGR of 3.70%during the forecasted period. According to Forecasts, the market would be worth USD 201.8 Million by 2033, up from USD 140.3 Million in 2023.
| Attributes | Details |
|---|---|
| Market size value in 2023 | USD 140.3 Million |
| Market forecast value in 2033 | USD 201.8 Million |
| Forecast period | 2023 to 2033 |
| Global growth rate (CAGR) | 3.70% |
| Share of Germany in The Psychobiotic Supplements Market | 22.50% |
Psychobiotics are a group of probiotics that influence the central nervous system's behaviour and associated processes via the gut brain-axis via immunological, neurological, humoral, and metabolic pathways to enhance not only gastrointestinal function but also anxiolytic capability and antidepressant. The psychobiotic supplements industry is being driven by increased health and wellness consciousness.
The global market for psychobiotic supplements is diversified and extremely competitive. Companies are boosting their R&D investment in order to create new and distinctive psychobiotic supplement items. Companies are developing new uses for psychobiotics in order to gain a competitive edge.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
According to Future Market Insights, the Psychobiotic Supplements market was growing at a CAGR of 3.50% to reach USD 135.6 million in 2022 from USD 118.2 million in 2018.
North America currently holds the largest market share in the psychobiotic supplements market. Psychobiotics are a new type of supplement that contain probiotics, which are living organisms that can improve general health and wellbeing. This growing sector is seeing increasing demand for these products due to their potential therapeutic effects on mental health issues such as depression and anxiety, as well as physical ailments like digestive problems.
The North American psychobiotic supplements market is estimated to grow at a compound annual growth rate (CAGR) of 11% between 2021 and 2028. This rapid growth can be attributed to factors such as increasing prevalence of mental disorders, rising investments in research and development for novel products, and growing awareness about the benefits of psychobiotics among consumers. Furthermore, an increase in online sales channels is also driving the growth of this sector.
Europe has become a lucrative and attractive market for the psychobiotic supplements industry. As the health and wellness industry continues to grow, consumers are looking for natural remedies that are backed by science to improve their mental and physical wellbeing. In response, psychobiotic supplements - which contain probiotics formulated to help balance the body’s hormones and boost mood - have emerged as one of the most popular products on the market in Europe.
The main benefit of selling psychobiotic supplements in Europe is that there is a large consumer base who are aware of its potential benefits. The European Union (EU) is home to around 450 million people who are increasingly open to trying new products that can improve their mental health without pharmaceuticals or chemical-based solutions.
The Asia Pacific region is quickly emerging as one of the most opportunistic markets for psychobiotic supplements. With its rapidly-growing population and increased awareness of mental health, this sector is becoming increasingly attractive to investors. The increasing number of people seeking natural remedies for mental health conditions such as anxiety, depression, and stress are driving the growth in demand for these products. This has created an ideal environment for companies to enter the market and capitalize on the growing popularity of psychobiotic supplements in Asia Pacific.
The ability to access a large pool of potential customers has led to a surge in investment into this field from venture capitalists and pharmaceutical companies alike. The availability of efficient manufacturing processes within the region has also allowed companies to produce high-quality products at competitive prices, which helps them gain a competitive edge over their competitors.
The food industry is a major player in the growth of the psychobiotic supplements market. Psychobiotics are supplements that contain probiotics and other components to provide psychological benefits, such as improved mood and better sleep. As people become more aware of their mental health, they are turning to these supplements as an alternative solution to traditional medications. This growing interest has lead to increased demand for psychobiotic products, which the food industry is responding to in various ways.
One way the food industry is supporting the growth of this market is by introducing new products with psychobiotic ingredients. Companies are now offering foods like yogurt and cereal made with probiotics, which can easily be incorporated into a daily diet routine. These items make it easier for consumers to access these beneficial microbes without having to take extra pills or supplements throughout the day.
Psychobiotic supplements are gaining traction in the wellness industry, as they offer a range of mental and physical health benefits. By application, which category will experience maximum growth when it comes to psychobiotic supplements?
Experts suggest that probiotics geared towards athletes and bodybuilders have been increasing in popularity over recent years. This is due to their ability to improve recovery times and performance levels, while reducing feelings of stress, fatigue and emotional exhaustion. Studies also show that probiotics can help regulate metabolism and digestion, which is especially beneficial for those trying to reach certain fitness goals or lose weight.
The competitive landscape of the Psychobiotic Supplements market is an ever-evolving dynamic, with companies competing to provide consumers with the best possible solutions. As awareness of probiotics and their benefits continue to grow, so too has the demand for psychobiotic supplements. With this rising demand comes a wide range of product offerings from established brands as well as new entrants vying for consumer attention.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
| Attribute | Details |
|---|---|
| Forecast period | 2023 to 2033 |
| Historical data available for | 2018 to 2022 |
| Market analysis | USD million in value |
| Key regions covered | North America; Eastern Europe; Western Europe; Japan; South America; Asian pacific; Middle east and Africa |
| Key countries covered | USA, Germany, France, Italy, Canada, UK, Spain, China, India, Australia |
| Key segments covered | Application, Function, Distribution channel, Region |
| Key companies profiled | Lallemand Health Solutions Inc.; DuPont; BioGaia; Uplift Food Pty Ltd.; Kerry Group; NEURAXPHARM; Nature's Bounty Co.; Life Extension; Bened Biomedical Co.; Ltd.; Lifted Naturals |
| Report coverage | Market Forecast, Company Share Analysis, DROT Analysis, Market Dynamics, Competitive Landscape, Challenges, Strategic Growth Initiatives |
| Customization and Pricing |
Available upon request |
The Psychobiotic Supplements market size is assessed to USD 140.3 Million in 2023.
The Psychobiotic Supplements market is expected to rise at a CAGR of 3.70%.
USA, China, Canada, Germany, China, India, UK, Australia are the major countries driving demand for Psychobiotic Supplements market.
China Psychobiotic Supplements market is projected to grow at a CAGR of around 5.60% over the next ten years.
Market share of Germany in Psychobiotic Supplements market is about 22.50% of the global market.
Lallemand Health Solutions Inc., DuPont, BioGaia, Uplift Food Pty Ltd., Kerry Group are expected to be the top players driving the market growth.
The global Psychobiotic Supplements market is forecasted to surpass USD 201.8 Million by the end of 2033.
| Estimated Market Size (2024E) | USD 7,524.6 million |
|---|---|
| Projected Market Value (2034F) | USD 23,874.5 million |
| Value-based CAGR (2024 to 2034) | 11.2% |
| Estimated Market Size (2024E) | USD 74.3 billion |
|---|---|
| Projected Market Valuation (2034F) | USD 170.1 billion |
| Value-based CAGR (2024 to 2034) | 9.5% |
| Market Size in 2023 | USD 17,160 million |
|---|---|
| Market Forecast in 2033 | USD 29,648.6 million |
| Market CAGR (2023 to 2033) | 6% |
Explore Food Supplement and Nutrition Insights
View Reports
Psychobiotic Supplements Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
